LONDON/COPENHAGEN (Reuters) -Novo Nordisk has appointed U.S. pharmaceutical executive Greg Miley as its new head of corporate affairs, according to a statement he posted on LinkedIn, as the obesity drugmaker faces growing pressure from the Trump administration on drug pricing. Miley, an American, is currently senior vice president of government affairs at U.S. pharmaceutical giant AbbVie. He posted the statement on LinkedIn on Friday and Novo Nordisk shared the statement with Reuters. (Reporting by Maggie Fick in London and Stine Jacobsen in Copenhagen, Editing by Louise Heavens)
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
प्रमाणित स्रोत से लेकर टेक्नोलॉजी-संचालित नेचुरल डायमंड सॉलिटेयर ज्वेलरी प्रोग्राम तक, अंकित जेम्स का नया…
71 काव्य-रचनाओं की त्रि-आयामी युग–काव्य–संहिता को विश्व कीर्तिमान की मान्यता; राही को मिला वैश्विक साहित्य…
A legend on the silver screen, two-time Oscar winner Anthony Hopkins has now brought out…
Berlin (dpa) – For fans, there is nothing like a well-cooked steak, with a crispy…
A teacher and a parenting expert outline key signs the new term is causing issues…
Cologne (dpa) - Take the time to make your own cheese ravioli at home. You…